Consistent with previous studies [9,12,44], we observed decreased SOD enzyme activity and reduced TAC levels in plasma samples from AD patients, although the CAT enzyme activity and the levels of the FRAP marker did not show significant differences. The gene discussed is CAT; the disease is Alzheimer disease.